863 Trips
1,606 itineraries translated into French, Portuguese and Spanish
4 COUNTRIES | 7 SITES
Argentina, Brazil, France, US
BBK Worldwide was engaged by a leading pharmaceutical company for more than six years to provide clinical study travel and reimbursement services for patients with familial amyloid polyneuropathy, a rare, inherited and progressive disease.
While our initial engagement focused on reimbursement, it expanded to include travel and then concluded with the introduction of medication delivery to support patients impacted by COVID-19 lockdown measures.
In the final year of BBK’s engagement, COVID-19 proved to be an unexpected challenge. It required a quick pivot to a solution that would support patients who needed to remain at home during lockdown. With speed and dexterity, we implemented our medication delivery service.
Medication was packaged at the site and then shipped directly to patients’ homes using ground and air methods. The shipments needed to be temperature-controlled between 2 and 8 degrees Celsius and ready for patients to self-administer upon delivery. The success of this program ensured that study participants were able to remain compliant with the protocol and that the sponsor was able to complete the study as planned.
Reimbursement categories: meals, mileage, parking, lodging, ground transport, airfare, COVID-19 tests
Argentina, Brazil, France, Spain, UK, US
1,606 itineraries translated into French, Portuguese and Spanish
Argentina, Brazil, France, US
Download the PDF version of this case study today:
Case Studies
March 23, 2023
Case Studies
March 23, 2023
Case Studies
March 23, 2023
BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States
Terms & Conditions Privacy Policy
© 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.
Terms & Conditions Privacy Policy
© 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.